X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1141) 1141
Book Review (168) 168
Publication (110) 110
Book Chapter (19) 19
Book / eBook (8) 8
Conference Proceeding (5) 5
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (785) 785
humans (716) 716
equivalence (543) 543
clinical trials (215) 215
female (213) 213
statistics & probability (205) 205
male (199) 199
pharmacology & pharmacy (165) 165
treatment outcome (157) 157
medicine, research & experimental (150) 150
research design (150) 150
therapeutic equivalency (150) 150
analysis (144) 144
equivalence trials as topic (140) 140
models, statistical (134) 134
sample size (128) 128
adult (125) 125
research (123) 123
studies (118) 118
public, environmental & occupational health (117) 117
data interpretation, statistical (110) 110
clinical-trials (109) 109
confidence intervals (105) 105
middle aged (97) 97
medical informatics (92) 92
non-inferiority (87) 87
medicine (86) 86
design (84) 84
mathematical & computational biology (81) 81
psychology (78) 78
randomized controlled trials as topic - methods (75) 75
clinical trials as topic - methods (73) 73
noninferiority (71) 71
computer simulation (70) 70
statistics (68) 68
children (67) 67
clinical trials as topic - statistics & numerical data (66) 66
efficacy (66) 66
young adult (65) 65
aged (64) 64
randomized controlled trials as topic (64) 64
clinical trials as topic (63) 63
time factors (63) 63
health care sciences & services (61) 61
behavior (59) 59
adolescent (57) 57
algorithms (56) 56
bioequivalence (56) 56
trials (56) 56
methods (55) 55
stimulus equivalence (54) 54
randomized controlled trials as topic - statistics & numerical data (53) 53
medical research (52) 52
quality of life (52) 52
united states (52) 52
safety (51) 51
therapeutic equivalence (50) 50
issues (49) 49
models (49) 49
animals (48) 48
mathematical models (48) 48
tests (48) 48
behavioral sciences (46) 46
power (46) 46
study protocol (46) 46
usage (46) 46
health aspects (45) 45
psychology, experimental (45) 45
statistical methods (45) 45
care and treatment (44) 44
child (44) 44
patients (44) 44
medicine & public health (43) 43
medicine, general & internal (43) 43
drug therapy (42) 42
abridged index medicus (41) 41
null hypothesis (41) 41
article (40) 40
equivalence trial (40) 40
placebos (40) 40
reproducibility of results (39) 39
statistical analysis (39) 39
statistics as topic (39) 39
comparative analysis (38) 38
double-blind method (38) 38
equivalence trials (38) 38
multicenter studies as topic (38) 38
psychology, clinical (38) 38
questionnaires (38) 38
bias (37) 37
neurosciences (36) 36
psychology, biological (36) 36
psychology, general (36) 36
risk (36) 36
management (35) 35
quality (35) 35
health policy & services (34) 34
meta-analysis (34) 34
research design - standards (34) 34
surgery (34) 34
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2007, 1. Aufl., Statistics in practice, ISBN 0470094753, xi, 311
Studies in bioequivalence are the commonly accepted method to demonstrate therapeutic equivalence between two medicinal products. Savings in time and cost are... 
Drugs | Clinical Trials | methods | Drug Design | Therapeutic Equivalency | Biostatistics | Medical | Therapeutic equivalency
Book
Annals of Internal Medicine, ISSN 0003-4819, 09/2000, Volume 133, Issue 6, pp. 455 - 463
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10079, pp. 1630 - 1638
Summary Background Bullous pemphigoid is a blistering skin disorder with increased mortality. We tested whether a strategy of starting treatment with... 
Internal Medicine | MORTALITY | MEDICINE, GENERAL & INTERNAL | TOPICAL CORTICOSTEROIDS | MANAGEMENT | DISEASES | TETRACYCLINES | STEROIDS | DERMATOLOGISTS | ASSOCIATION | Glucocorticoids - therapeutic use | Administration, Oral | Doxycycline - therapeutic use | Humans | Middle Aged | Pemphigoid, Bullous - drug therapy | Male | Treatment Outcome | United Kingdom | Clinical Trials as Topic | Anti-Bacterial Agents - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Prednisolone - therapeutic use | Equivalence Trials as Topic | Germany | Clinical trials | Corticosteroids | Bullous pemphigoid | Prednisolone | Doxycycline | Steroids | Analysis | Corticoids | Parkinson's disease | Mobility | Antiinfectives and antibacterials | Information dissemination | Incidence | Proteins | Toxicology | Skin diseases | Libraries | Diagnosis | Movement disorders | Autoantibodies | Neurodegenerative diseases | Dermatology | Decision making | Mortality | Contraception | Patients | Side effects | Thinning | Tetracyclines | Documents | Adults | Added value | Intervention | Drugs | Arches | Immunoglobulin G | Medical services | Viruses | Reduction | Safety engineering | Constrictions | Diuretics | Dementia disorders | Safety | Age | Medical personnel | Hum | Stroke | Steering | Hematology | Hypersensitivity | Pharmacology | Inflammation | Adhesion | Consultants | Surveys | Pregnancy | Antibiotics | Autoimmune diseases | Elderly | Inhabitants | Index Medicus | Abridged Index Medicus
Journal Article
Archives of physical medicine and rehabilitation, ISSN 0003-9993, 04/2019
To investigate if shorter immobilization is noninferior to longer immobilization after Weilby procedure for thumb carpometacarpal osteoarthritis DESIGN:... 
Journal Article
Diabetes obesity & metabolism, ISSN 1462-8902, 07/2017, Volume 19, Issue 7, pp. 926 - 935
Two large cardiovascular outcome trials of canagliflozin, comprising the CANVAS Program, will complete in early 2017: the CANagliflozin cardioVascular... 
cardiovascular disease | type 2 diabetes | inhibitor | SGLT2 | SGLT2 inhibitor | DESIGN | EVENTS | EFFICACY | SAFETY | RATIONALE | CANAGLIFLOZIN CARDIOVASCULAR ASSESSMENT | CONJUNCTION | BASE-LINE CHARACTERISTICS | ENDOCRINOLOGY & METABOLISM | PLACEBO-CONTROLLED TRIAL | Follow-Up Studies | Diabetic Cardiomyopathies - mortality | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Diabetes Mellitus, Type 2 - metabolism | Dose-Response Relationship, Drug | Cardiovascular Diseases - complications | Hypoglycemic Agents - administration & dosage | Canagliflozin - therapeutic use | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Diabetic Cardiomyopathies - prevention & control | Female | Diabetic Angiopathies - prevention & control | Equivalence Trials as Topic | Diabetes Mellitus, Type 2 - complications | Canagliflozin - administration & dosage | Hypoglycemic Agents - therapeutic use | Reproducibility of Results | Double-Blind Method | Sodium-Glucose Transporter 2 - metabolism | Mortality | Risk Factors | Diabetic Angiopathies - mortality | Biomarkers - blood | Canagliflozin - adverse effects | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Diabetes Mellitus, Type 2 - mortality | Diabetic Cardiomyopathies - epidemiology | Diabetic Angiopathies - epidemiology | Aged | Diabetes Mellitus, Type 2 - drug therapy | Drug Monitoring | Hypoglycemic Agents - adverse effects | Cohort Studies | Type 2 diabetes | Index Medicus | Clinical Trial Design
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 01/2019, Volume 33, Issue 1, pp. 42 - 55
There is increasing use of head‐to‐head clinical trials in dermatology when establishing the efficacy of a new treatment. Active comparator trials ( ACT s) can... 
MODERATE | PLACEBO | CHRONIC PLAQUE PSORIASIS | EFFICACY | SAFETY | PHASE-III | DOUBLE-BLIND | VS. METHOTREXATE | RANDOMIZED CLINICAL-TRIALS | ETANERCEPT | DERMATOLOGY | Biomedical Research | Statistics as Topic | Psoriasis - drug therapy | Equivalence Trials as Topic | Research Design | Humans | Index Medicus
Journal Article
Journal of Ayub Medical College, Abbottabad : JAMC, ISSN 1025-9589, 07/2017, Volume 29, Issue 3, pp. 371 - 372
Journal Article
The Journal of the Association of Physicians of India, ISSN 0004-5772, 02/2017, Volume 65, Issue 2, pp. 70 - 73
Journal Article
Trials, ISSN 1745-6215, 02/2018, Volume 19, Issue 1, pp. 131 - 131
Journal Article